You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CHD-risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Disease Trial (MK0653, ezetimibe / Duration of Treatment: 27 Weeks, MK0733, simvastatin / Duration of Treatment: 27

Completed
  • Coronary Disease
  • MK0653, ezetimibe / Duration of Treatment: 27 Weeks
  • +2 more
  • (no location specified)
Feb 7, 2022

Procedure for Adjustment of Risk Factors in Coronary Heart

Recruiting
  • Coronary Artery Disease
  • +3 more
  • CHD therapy through iATROS medical device
  • Munich, Bayern, Germany
    Klinikum der Ludwig-Maximilians-Universität München (Klinikum de
Oct 18, 2023

Type 2 Diabetes Trial in China (Alogliptin, Acarbose, Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • China, China
    CHINA
Apr 18, 2022

sessmenT and treAtment In AustraliaN Primary Care

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • +3 more
  • Inclisiran Prefilled Syringe
  • Clayton, Victoria, Australia
    Monash Health
Apr 17, 2023

Genetic Markers of CHD Risk in Men and Women

Completed
  • Cardiovascular Diseases
  • +4 more
    • (no location specified)
    Apr 13, 2021

    AKI, CHD - Congenital Heart Disease, Surgery Trial in Cincinnati (Nitric Oxide, Oxygen)

    Recruiting
    • AKI
    • +2 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Apr 6, 2022

    On Liprimar In Coronary Heart Disease And High Risk Of

    Completed
    Has Results
    • Cardiovascular Diseases
    • Coronary Artery Disease
    • (no location specified)
    Feb 16, 2021

    Dermatitis, Atopic Trial in France (PREBIOTICS, PLACEBO)

    Recruiting
    • Dermatitis, Atopic
    • PREBIOTICS
    • PLACEBO
    • Angers, France
    • +5 more
    Jun 11, 2021

    Coronary Heart Disease Trial in Germany, United States (Placebo, dalcetrapib)

    Completed
    Has Results
    • Coronary Heart Disease
    • Chicago, Illinois
    • +16 more
    Jan 24, 2020

    Dyslipidemias Trial in Belgium (Atorvastatin)

    Completed
    • Dyslipidemias
    • Antwerpen, Belgium
    • +14 more
    Feb 17, 2021

    Coronary Heart Disease Trial in Worldwide (Placebo, dalcetrapib)

    Completed
    Has Results
    • Coronary Heart Disease
    • Feldkirch, Austria
    • +22 more
    Dec 13, 2019

    Multiple Myeloma Trial in France (Carfilzomib, Daratumumab, Lenalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Nantes, Pays De La Loire, France
    • +11 more
    Apr 27, 2021

    Fitness Trackers, Sedentary Time, Genetic Predisposition to Disease Trial (Genetic Risk Estimate+Health Coaching, Genetic Risk

    Not yet recruiting
    • Fitness Trackers
    • +3 more
    • Genetic Risk Estimate+Health Coaching
    • Genetic Risk Estimate + Fitbit Functions+Health Coaching
    • (no location specified)
    Mar 16, 2023

    Frailty and Non-Fragile Congenital Heart Disease

    Not yet recruiting
    • Congenital Heart Disease
    • Frailty
    • Observational
    • (no location specified)
    Apr 10, 2023

    Using Digital Data to Predict CHD

    Recruiting
    • Cardiovascular Diseases
    • Survey
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Jan 7, 2022

    Coronary Heart Disease, Cardiovascular Risk Factor, Arterial Stiffness Trial in Loughborough (Exercise)

    Completed
    • Coronary Heart Disease
    • +4 more
    • Exercise
    • Loughborough, United Kingdom
      Loughborough University
    Aug 16, 2022

    Cardiovascular Primary Prevention Strategy Trial (Coronary Computed Tomography Angiography, Standard Treatment)

    Not yet recruiting
    • Cardiovascular Primary Prevention Strategy
    • Coronary Computed Tomography Angiography
    • Standard Treatment
    • (no location specified)
    Jul 3, 2022

    Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)

    Not yet recruiting
    • Arteriosclerosis
    • Hypercholesterolaemia
    • (no location specified)
    Aug 17, 2023

    Cardiology, Infant Development, Development Delay Trial in Boston (NIDCAP Developmental Care)

    Not yet recruiting
    • Cardiology
    • +2 more
    • NIDCAP Developmental Care
    • Boston, Massachusetts
      Boston Children's Hospital
    May 31, 2023

    Coronary Heart Disease Trial in Canada, United States (Dalcetrapib (RO4607381), Placebo)

    Completed
    Has Results
    • Coronary Heart Disease
    • Dalcetrapib (RO4607381)
    • Placebo
    • Jacksonville, Florida
    • +11 more
    Dec 16, 2019

    Congenital Heart Disease Trial in Atlanta (High Flow Nasal Canula following extubation, Non-Invasive Positive Pressure

    Not yet recruiting
    • Congenital Heart Disease
    • High Flow Nasal Canula following extubation
    • Non-Invasive Positive Pressure Ventilation following extubation
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    May 19, 2023

    Heart Defects, Congenital, Pulmonary Arterial Hypertension, Genetic Testing Trial in Leuven (Genetic testing)

    Recruiting
    • Heart Defects, Congenital
    • +2 more
    • Genetic testing
    • Leuven, Belgium
      University Hospitals Leuven
    May 17, 2022

    Coronary Heart Disease Trial in Cleveland (PAL2, CINEMA)

    Recruiting
    • Coronary Heart Disease
    • PAL2
    • CINEMA
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Jun 15, 2023

    Congenital Heart Disease, Child Development, Early Intervention Trial in Porto Alegre (Remotely monitored parent-mediated hybrid

    Recruiting
    • Congenital Heart Disease
    • +2 more
    • Remotely monitored parent-mediated hybrid home and clinic based multidisciplinary Early Intervention protocols.
    • Porto Alegre, Rio Grande Do Sul, Brazil
    • +1 more
    Jun 8, 2023

    Depressed Patients With Coronary Heart Disease - R01HL147862

    Recruiting
    • Coronary Heart Disease
    • Depression
    • Other
    • Saint Louis, Missouri
      Washington University
    Mar 30, 2022